Proteomic analysis reveals that apolipoprotein A1 levels are decreased in patients with Budd-Chiari syndrome

Simone Talens, Jildou Hoekstra, Steffen P G Dirkx, Sarwa Darwish Murad, Jonel Trebicka, Elwyn Elias, Massimo Primignani, Juan Carlos García-Pagán, Dominique C. Valla, Harry L A Janssen, Frank W G Leebeek, Dingeman C. Rijken

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background & Aims: Budd-Chiari syndrome (BCS) is a rare vascular liver disorder caused by thrombosis of the hepatic veins. In some patients, no known thrombophilic factor can be identified. This study aimed to identify novel factors that might play a role in thrombosis in BCS-patients by using a proteomic approach. Methods: The abundance of plasma clot-bound proteins was compared between nine BCS-patients and nine controls by using two-dimensional difference gel electrophoresis. The protein with the most significant decrease in patients was identified by mass spectrometry. Plasma levels of this protein were measured and the results were validated in a large cohort of BCS-patients. Results: A total of 26 protein spots significantly differed (p

Original languageEnglish
Pages (from-to)908-914
Number of pages7
JournalJournal of Hepatology
Volume54
Issue number5
DOIs
Publication statusPublished - May 2011

Fingerprint

Budd-Chiari Syndrome
Apolipoprotein A-I
Proteomics
Two-Dimensional Difference Gel Electrophoresis
Proteins
Blood Vessels
Blood Proteins
Mass Spectrometry
Thrombosis
Liver

Keywords

  • 2D-DIGE
  • Apolipoprotein A1
  • Budd-Chiari syndrome
  • Proteomics
  • Venous thrombosis

ASJC Scopus subject areas

  • Hepatology

Cite this

Talens, S., Hoekstra, J., Dirkx, S. P. G., Murad, S. D., Trebicka, J., Elias, E., ... Rijken, D. C. (2011). Proteomic analysis reveals that apolipoprotein A1 levels are decreased in patients with Budd-Chiari syndrome. Journal of Hepatology, 54(5), 908-914. https://doi.org/10.1016/j.jhep.2010.08.026

Proteomic analysis reveals that apolipoprotein A1 levels are decreased in patients with Budd-Chiari syndrome. / Talens, Simone; Hoekstra, Jildou; Dirkx, Steffen P G; Murad, Sarwa Darwish; Trebicka, Jonel; Elias, Elwyn; Primignani, Massimo; García-Pagán, Juan Carlos; Valla, Dominique C.; Janssen, Harry L A; Leebeek, Frank W G; Rijken, Dingeman C.

In: Journal of Hepatology, Vol. 54, No. 5, 05.2011, p. 908-914.

Research output: Contribution to journalArticle

Talens, S, Hoekstra, J, Dirkx, SPG, Murad, SD, Trebicka, J, Elias, E, Primignani, M, García-Pagán, JC, Valla, DC, Janssen, HLA, Leebeek, FWG & Rijken, DC 2011, 'Proteomic analysis reveals that apolipoprotein A1 levels are decreased in patients with Budd-Chiari syndrome', Journal of Hepatology, vol. 54, no. 5, pp. 908-914. https://doi.org/10.1016/j.jhep.2010.08.026
Talens, Simone ; Hoekstra, Jildou ; Dirkx, Steffen P G ; Murad, Sarwa Darwish ; Trebicka, Jonel ; Elias, Elwyn ; Primignani, Massimo ; García-Pagán, Juan Carlos ; Valla, Dominique C. ; Janssen, Harry L A ; Leebeek, Frank W G ; Rijken, Dingeman C. / Proteomic analysis reveals that apolipoprotein A1 levels are decreased in patients with Budd-Chiari syndrome. In: Journal of Hepatology. 2011 ; Vol. 54, No. 5. pp. 908-914.
@article{0cc0c52831a44b51b2f83bf205651242,
title = "Proteomic analysis reveals that apolipoprotein A1 levels are decreased in patients with Budd-Chiari syndrome",
abstract = "Background & Aims: Budd-Chiari syndrome (BCS) is a rare vascular liver disorder caused by thrombosis of the hepatic veins. In some patients, no known thrombophilic factor can be identified. This study aimed to identify novel factors that might play a role in thrombosis in BCS-patients by using a proteomic approach. Methods: The abundance of plasma clot-bound proteins was compared between nine BCS-patients and nine controls by using two-dimensional difference gel electrophoresis. The protein with the most significant decrease in patients was identified by mass spectrometry. Plasma levels of this protein were measured and the results were validated in a large cohort of BCS-patients. Results: A total of 26 protein spots significantly differed (p",
keywords = "2D-DIGE, Apolipoprotein A1, Budd-Chiari syndrome, Proteomics, Venous thrombosis",
author = "Simone Talens and Jildou Hoekstra and Dirkx, {Steffen P G} and Murad, {Sarwa Darwish} and Jonel Trebicka and Elwyn Elias and Massimo Primignani and Garc{\'i}a-Pag{\'a}n, {Juan Carlos} and Valla, {Dominique C.} and Janssen, {Harry L A} and Leebeek, {Frank W G} and Rijken, {Dingeman C.}",
year = "2011",
month = "5",
doi = "10.1016/j.jhep.2010.08.026",
language = "English",
volume = "54",
pages = "908--914",
journal = "Journal of Hepatology",
issn = "0168-8278",
publisher = "Elsevier B.V.",
number = "5",

}

TY - JOUR

T1 - Proteomic analysis reveals that apolipoprotein A1 levels are decreased in patients with Budd-Chiari syndrome

AU - Talens, Simone

AU - Hoekstra, Jildou

AU - Dirkx, Steffen P G

AU - Murad, Sarwa Darwish

AU - Trebicka, Jonel

AU - Elias, Elwyn

AU - Primignani, Massimo

AU - García-Pagán, Juan Carlos

AU - Valla, Dominique C.

AU - Janssen, Harry L A

AU - Leebeek, Frank W G

AU - Rijken, Dingeman C.

PY - 2011/5

Y1 - 2011/5

N2 - Background & Aims: Budd-Chiari syndrome (BCS) is a rare vascular liver disorder caused by thrombosis of the hepatic veins. In some patients, no known thrombophilic factor can be identified. This study aimed to identify novel factors that might play a role in thrombosis in BCS-patients by using a proteomic approach. Methods: The abundance of plasma clot-bound proteins was compared between nine BCS-patients and nine controls by using two-dimensional difference gel electrophoresis. The protein with the most significant decrease in patients was identified by mass spectrometry. Plasma levels of this protein were measured and the results were validated in a large cohort of BCS-patients. Results: A total of 26 protein spots significantly differed (p

AB - Background & Aims: Budd-Chiari syndrome (BCS) is a rare vascular liver disorder caused by thrombosis of the hepatic veins. In some patients, no known thrombophilic factor can be identified. This study aimed to identify novel factors that might play a role in thrombosis in BCS-patients by using a proteomic approach. Methods: The abundance of plasma clot-bound proteins was compared between nine BCS-patients and nine controls by using two-dimensional difference gel electrophoresis. The protein with the most significant decrease in patients was identified by mass spectrometry. Plasma levels of this protein were measured and the results were validated in a large cohort of BCS-patients. Results: A total of 26 protein spots significantly differed (p

KW - 2D-DIGE

KW - Apolipoprotein A1

KW - Budd-Chiari syndrome

KW - Proteomics

KW - Venous thrombosis

UR - http://www.scopus.com/inward/record.url?scp=79954685076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954685076&partnerID=8YFLogxK

U2 - 10.1016/j.jhep.2010.08.026

DO - 10.1016/j.jhep.2010.08.026

M3 - Article

VL - 54

SP - 908

EP - 914

JO - Journal of Hepatology

JF - Journal of Hepatology

SN - 0168-8278

IS - 5

ER -